Alzinova AB (FRA:78D) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:78D Alzinova AB FRA:78D
21 GF Score
Price €0.05
! 1 Warning Sign
View Full Analysis

What is Alzinova AB FFO per Share?

FFO per Share only applies to REITs.

FRA:78D
21GF Score
Alzinova AB FRA:78D
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzinova AB Business Description

Other Exchanges ALZ:Sweden78D:Germany
Address Entreprenorsstraket 10, Molndal, SWE, 431 53
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.
21GF Score

Get the complete analysis for FRA:78D

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price